CVRx Launches a new Barostim™ Programmer

2 years ago

The new Barostim Programmer launches in the U.S., making Barostim therapy programming simpler and enabling remote view access to enhance…

Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors

2 years ago

SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering…

Bioventus Completes CartiHeal Acquisition

2 years ago

DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…

Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument

2 years ago

ROSELAND, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,…

WIMI Hologram Academy: The Study of Holographic Communication of Dark Matter Particles

2 years ago

HONG KONG, July 12, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center, has…

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP

2 years ago

• CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022…

NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology

2 years ago

Funds will be used to develop hybrid seed technology in wheat and rice through gene editing of plant mitochondriaWILMINGTON, Del.,…

BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia

2 years ago

SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], Sunnyvale, Calif. – BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and…

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

2 years ago

MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…

Agile Therapeutics Updates Second Quarter 2022 Guidance

2 years ago

Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses (OPEX) Expected to be Below…